Articles for tag: cardimyopathy, clozapine, coroner, death, duty of care, guidance, guidelines, heart, pfd, psychiatry, risk, treatment-resistant schizophrenia

Clozapine-Associated Cardiac Pathologies

Clozapine, an atypical antipsychotic medication, is widely recognised as the most effective treatment for individuals with treatment-resistant schizophrenia (TRS).1 Approved in 1989, its utilisation has grown, particularly for patients who have not responded adequately to other antipsychotic agents.3 Despite its superior therapeutic efficacy, clozapine carries a significant cautionary “black box warning” due to its association with rare but serious adverse effects, most notably agranulocytosis, but also considerable cardiovascular risks.5 It is important to note that, despite these risks, population-level studies ...

blank

Clozapine – including lessons from the Coroner

Clozapine is a unique antipsychotic medication that plays a crucial role in treating severe mental health conditions. It is the only drug proven effective for treatment-resistant schizophrenia, offering hope to patients who have not responded to other treatments. See also: Treatment Resistant Schizophrenia. However, its use comes with strict monitoring requirements due to potential serious side effects, including risks to blood health and the heart. This article explores clozapine’s licenced and unlicenced uses, its historical development, and the protocols for ...